Skip to main content
JIN YANG PHARMACEUTICAL. CO., LTD logo

JIN YANG PHARMACEUTICAL. CO., LTD — Investor Relations & Filings

Ticker · 007370 ISIN · KR7007370000 KO Manufacturing
Open in API
Filings indexed 210 across all filing types
Latest filing 2023-03-22 Board/Management Inform…
Country KR South Korea
Listing KO 007370

About JIN YANG PHARMACEUTICAL. CO., LTD

https://www.jinyangpharm.com/

JIN YANG PHARMACEUTICAL. CO., LTD. is a company engaged in the research, development, manufacturing, and sale of pharmaceutical products, with a primary focus on prescription drugs. The company operates a fully automated, high-tech manufacturing facility. Its research and development efforts are dedicated to creating advanced preventive and therapeutic treatments for various diseases. Key areas of R&D include the development of anticancer drugs through molecular biology research, particularly for leukemia, and therapies for metabolic disorders such as diabetes and obesity. The company also develops antivirals and explores formulations based on herbal preparations.

Recent filings

Filing Released Lang Actions
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's leadership (appointment of an additional representative director). It explicitly lists the 'before' and 'after' status of the CEO/Representative Director, the reason for the change (Board resolution), and the date of the change. This falls directly under the category of Board/Management Information (MANG).
2023-03-22 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Convocation of Annual General Meeting' (주주총회소집공고) for Jinyang Pharmaceutical. It contains the meeting agenda, financial statements (balance sheet, income statement, etc.), and management information required for shareholders to vote. While it contains financial data, it is primarily a proxy statement/notice for an upcoming shareholder meeting, which falls under the Proxy Solicitation & Information Statement category.
2023-03-15 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system titled 'Audit Report Submission' (감사보고서 제출). It provides the auditor's opinion, key financial data, and confirmation of the audit completion for the fiscal year. While it contains financial data, it is a summary disclosure of the audit results rather than the full Annual Report (10-K) or a standalone audit report document. According to the 'Menu vs Meal' rule, this is a formal regulatory announcement of the audit report's submission, which fits the 'Report Publication Announcement' (RPA) category. FY 2022
2023-03-14 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Jinyang Pharmaceutical Co., Ltd. for the 45th fiscal year (2022). It contains comprehensive financial information, business overview, management discussion, and corporate governance details, which is the standard format for an annual report in the South Korean regulatory system (DART). It is not an announcement of a report, but the report itself. FY 2022
2023-03-14 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for Jinyang Pharmaceutical. It contains the meeting agenda, details on voting procedures, and comprehensive financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement) for the 45th fiscal year. While it includes financial data, it is primarily a proxy statement/notice for shareholders to inform them of the upcoming AGM and the items to be voted upon, which aligns with the Proxy Solicitation & Information Statement (PSI) category.
2023-03-07 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often filed under the Financial Supervisory Service) used to solicit votes from shareholders for an upcoming Annual General Meeting (AGM). It contains the agenda items, financial statements, and proxy solicitation details. While it contains financial data, it is not an Annual Report (10-K) or an Earnings Release (ER), but rather a proxy solicitation document. Therefore, it fits the 'Proxy Solicitation & Information Statement' category.
2023-03-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.